title: Zolmitriptan for treatment of migrainous vertigo: a pilot randomized placebo-controlled trial.
authors.affiliation: Neurologische Klinik, Charité, Humboldt-Universität, Berlin, Germany. neuhauserh@rki.de
authors.forename: H
authors.initials: H
authors.lastname: Neuhauser
authors.forename: A
authors.initials: A
authors.lastname: Radtke
authors.forename: M
authors.initials: M
authors.lastname: von Brevern
authors.forename: T
authors.initials: T
authors.lastname: Lempert
mesh_terms: D000284:Administration, Oral; D000328:Adult; D000368:Aged; D018592:Cross-Over Studies; D004311:Double-Blind Method; D006801:Humans; D008875:Middle Aged; D008881:Migraine Disorders / Q000150:complications / Q000188:drug therapy*; D023303:Oxazolidinones / Q000627:therapeutic use*; D016896:Treatment Outcome; D014363:Tryptamines; D014717:Vertigo / Q000150:complications / Q000188:drug therapy*
chemical_list: D023303:Oxazolidinones; D014363:Tryptamines; C089750:zolmitriptan